Mashio Nakamura - Department of Cardiology, Mie University Graduate School of Medicine, Tsu, Japan

基本信息

浏览量：124

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 280 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CORRIGENDUM: Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice　- A Post-Marketing Surveillance

Norikazu Yamada,Makoto Mo, Ako Ohsawa, Motoki Sato, Michiaki Umeyama, Daisuke Shima,Mashio Nakamura

Circulation journal : official journal of the Japanese Circulation Societyno. 2 (2024): 263-263

引用0浏览0WOS引用

Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis

Mashio Nakamura, Masato Sakon, Mitsuru Sasako,Takuji Okusaka,Hirofumi Mukai, Keiichi Fujiwara,Hideo Kunitoh, Mari S Oba,Hideo Wada, Jun Hosokawa, Atsushi Takita,Masataka Ikeda

International journal of clinical oncologyno. 4 (2024): 407-416

引用0浏览0WOS引用

Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice D A Post-Marketing Surveillance D

Norikazu Yamada,Makoto Mo, Ako Ohsawa, Motoki Sato, Michiaki Umeyama, Daisuke Shima,Mashio Nakamura

CIRCULATION JOURNALno. 2 (2024)

引用0浏览0引用

Efficacy and Safety of Warfarin for the Treatment of Venous Thromboembolism D A Multicenter Prospective Observational Cohort Study in Japan (AKAFUJI Study)

Mashio Nakamura,Satoshi Tamaru, Shigeki Hirooka,Atsushi Hirayama,Akihiro Tsuji, Mitsuhiro Hirata, Mitsuru Munemasa, Izumi Nakagawa, Masahiro Toshima,Hiroaki Shimokawa,Yuki Nishimura,Toru Ogura,

CIRCULATION JOURNAL（2024）

引用0浏览0引用

Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the Jxactly Study

Norikazu Yamada,Ikuo Fukuda,Mashio Nakamura,Morimasa Takayama,Hideaki Maeda,Takeshi Yamashita,Takanori Ikeda,Makoto Mo,Tsutomu Yamazaki,Yasuo Okumura,Atsushi Hirayama

ANNALS OF VASCULAR DISEASESno. 3 (2023): 181-188

引用0浏览0WOS引用

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study

Shohei Migita,Yasuo Okumura,Ikuo Fukuda,Mashio Nakamura,Norikazu Yamada,Morimasa Takayama,Hitoshi Maeda,Takeshi Yamashita,Takanori Ikeda,Makoto Mo,Tsutomu Yamazaki,Atsushi Hirayama

Thrombosis journal（2023）

引用0浏览0WOS引用

Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan　- Results From Post-Marketing Surveillance (XASSENT)

Ikuo Fukuda,Atsushi Hirayama,Kazuo Kawasugi,Takao Kobayashi,Hideaki Maeda,Mashio Nakamura,Norikazu Yamada,Tsubasa Tajima,Michiya Tachiiri,Yutaka Okayama,Toshiyuki Sunaya,Kazufumi Hirano,

Circulation journal : official journal of the Japanese Circulation Societyno. 9 (2023): 1175-+

引用1浏览0WOS引用

Efficacy and Safety of Warfarin for the Treatment of Venous Thromboembolism　- A Multicenter Prospective Observational Cohort Study in Japan (AKAFUJI Study)

Mashio Nakamura,Satoshi Tamaru, Shigeki Hirooka,Atsushi Hirayama,Akihiro Tsuji, Mitsuhiro Hirata, Mitsuru Munemasa, Izumi Nakagawa, Masahiro Toshima,Hiroaki Shimokawa,Yuki Nishimura,Toru Ogura,

Circulation journal : official journal of the Japanese Circulation Societyno. 3 (2023): 359-368

引用1浏览0WOS引用

Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J'xactly study

Shohei Migita,Yasuo Okumura,Ikuo Fukuda,Mashio Nakamura,Norikazu Yamada,Morimasa Takayama,Hideaki Maeda,Takeshi Yamashita,Takanori Ikeda,Makoto Mo,Tsutomu Yamazaki,Atsushi Hirayama

Front Cardiovasc Med（2023）

引用0浏览0WOS引用

Effectiveness and safety of rivaroxaban in patients with venous thromboembolism and active cancer: A subanalysis of the J'xactly study

Shinji Hisatake,Takanori Ikeda,Ikuo Fukuda,Mashio Nakamura,Norikazu Yamada,Morimasa Takayama,Hideaki Maeda,Takeshi Yamashita,Makoto Mo,Tsutomu Yamazaki,Yasuo Okumura,Atsushi Hirayama

Journal of Cardiology（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn